3rd Quarter - Report — CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC. (2020)

Firm

CRISPR THERAPEUTICS, INC.

Client

CRISPR THERAPEUTICS, INC.

Income

—

Expenses

$90,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Reimbursement for cell and gene therapies.

Lobbyist	Covered position, as disclosed
JOHN MARTIN	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB)

Health Issues HCR

Reimbursement for cell and gene therapies.

Lobbyist	Covered position, as disclosed
JOHN MARTIN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Reimbursements for cell and gene therapies

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Head of Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.